Por: Los Angeles Times Science September 18, 2023
Tennessee last year spent $48 million on a single drug, Humira — about $62,000 for each of the 775 patients who were covered by its employee health insurance program and receiving the treatment. So when nine Humira knockoffs, known as biosimilars, hit the market for as little as $995 a month, the opportunity for savings appeared ample and immediate. But it isn’t here yet. Makers of biosimilars must still work within a healthcare system in... + full article
WPLG Local 10 USA Health June 30, 2023
Patients who take the autoimmune disease treatment Humira may see some price relief when several lower-cost, biosimilar versions of the AbbVie drug reach the U.S. market in July. But lower pharmacy bills may not happen right away — or at all — for some patients. That'll... + más
Cheaper competition for Humira is hitting the market, but savings will depend on your insurance | ABC News
How a Drug Company Made $114 Billion by Gaming the U.S. Patent System | The New York Times
ABC News USA Health June 30, 2023
Cheaper competition for Humira is hitting the market, but savings will depend on your insurance | WPLG Local 10
Forbes USA Business March 27, 2023
Light Bulbs Concept Shining ETHICS, RESPECT, HONESTY and INTEGRITYgetty Previously, I wrote on in some detail, but did not go into the duties the Trustee of a Trust owes to the Trust’s beneficiary. To summarize, a Trust is an agreement written by the owner of the property,... + más
Selecting The Right Trustee To Manage Your Trust | Forbes
Author Post: Using Land Trusts For Anonymity And Asset Protection | Forbes
The New York Times USA Business January 28, 2023
In 2016, a blockbuster drug called Humira was poised to become a lot less valuable.The key patent on the best-selling anti-inflammatory medication, used to treat conditions like arthritis, was expiring at the end of the year. Regulators had blessed a rival version of the drug,... + más
Will More Women Patent Attorneys Lead To More Women Inventors? | Forbes
Samsung Beats IBM, Apple, Intel, Google For 2022 Patent Crown; 56% Of U.S. Patents Go To Foreign Firms | Forbes
ESPN USA Sports January 02, 2023
With just two weeks left in the , the is shaping up. More teams have claimed their spots in the NFC and AFC. However, the race to the playoffs continues as top teams in both conferences are still looking to lock in their spots for the and have a chance to do so in .The clinched... + más
NFL Playoff Scenarios | ABC News
NFL Week 16 playoff picture and clinching scenarios: Bills win AFC East, Ravens clinch playoff berth | ESPN
Forbes USA Tech December 05, 2022
Cigna’s pharmacy benefit manager Express Scripts will put “multiple biosimilar versions of Abbvie’s ... [+] expensive rheumatoid arthritis drug Humira in the “same position as the brand” on the PBM’s as a formulary in 2023. AbbVie's signature drug Humira is... + más
Cigna received millions of Medicare dollars based on invalid diagnoses, lawsuit claims | ABC News
How To Get Away With Corporate Murder: Unbundling And Disrupting Pharmacy Benefit Managers (Part 2) | Forbes
Los Angeles Times USA Sports November 06, 2022
This baseball season started late and ended later. We did not expect the Lakers to be done before the World Series was done, but here we are. This fall marked the debut of baseball’s grand new postseason. A sport that for generations prided itself on a regular season long... + más
Things to know as baseball postseason nears | Portland Press Herald
MLB playoff primer: Things to know as postseason nears | WPLG Local 10
About iurex | Privacy Policy | Disclaimer |